Cost of stroke in Australia from a societal perspective: results from the north east Melbourne stroke incidence study (NEMESIS)

Dewey, Helen M., Thrift, Amanda G., Mihalopoulos, Cathy, Carter, Rob, Macdonell, Richard A. L., McNeil, John J. and Donnan, Geoffrey A. 2001, Cost of stroke in Australia from a societal perspective: results from the north east Melbourne stroke incidence study (NEMESIS), Stroke, vol. 32, no. 10, pp. 2409-2416, doi: 10.1161/hs1001.097222.

Attached Files
Name Description MIMEType Size Downloads

Title Cost of stroke in Australia from a societal perspective: results from the north east Melbourne stroke incidence study (NEMESIS)
Author(s) Dewey, Helen M.
Thrift, Amanda G.
Mihalopoulos, CathyORCID iD for Mihalopoulos, Cathy
Carter, RobORCID iD for Carter, Rob
Macdonell, Richard A. L.
McNeil, John J.
Donnan, Geoffrey A.
Journal name Stroke
Volume number 32
Issue number 10
Start page 2409
End page 2416
Publisher Lippincott Williams & Wilkins
Place of publication Philadelphia, Pa.
Publication date 2001-10
ISSN 0039-2499
Keyword(s) Australia
cerebrovascular disorders
costs and cost analysis
Summary Background and Purpose—— Accurate information about resource use and costs of stroke is necessary for informed health service planning. The purpose of this study was to determine the patterns of resource use among stroke patients and to estimate the total costs (direct service use and indirect production losses) of stroke (excluding SAH) in Australia for 1997.

Methods—— An incidence-based cost-of-illness model was developed, incorporating data obtained from the North East Melbourne Stroke Incidence Study (NEMESIS). The costs of stroke during the first year after stroke and the present value of total lifetime costs of stroke were estimated.

The total first-year costs of all first-ever-in-a lifetime strokes (SAH excluded) that occurred in Australia during 1997 were estimated to be A$555 million (US$420 million), and the present value of lifetime costs was estimated to be A$1.3 billion (US$985 million). The average cost per case during the first 12 months and over a lifetime was A$18 956 (US$14 361) and A$44 428 (US$33 658), respectively. The most important categories of cost during the first year were acute hospitalization (A$154 million), inpatient rehabilitation (A$150 million), and nursing home care (A$63 million). The present value of lifetime indirect costs was estimated to be A$34 million.

Conclusions—— Similar to other studies, hospital and nursing home costs contributed most to the total cost of stroke (excluding SAH) in Australia. Inpatient rehabilitation accounts for {approx}27% of total first-year costs. Given the magnitude of these costs, investigation of the cost-effectiveness of rehabilitation services should become a priority in this community.
Language eng
DOI 10.1161/hs1001.097222
Field of Research 111799 Public Health and Health Services not elsewhere classified
Socio Economic Objective 970111 Expanding Knowledge in the Medical and Health Sciences
HERDC Research category C1.1 Refereed article in a scholarly journal
Copyright notice ©2001, American Heart Association, Inc.
Persistent URL

Document type: Journal Article
Collections: Faculty of Health
School of Health and Social Development
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 125 times in TR Web of Science
Scopus Citation Count Cited 149 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 873 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Thu, 31 Jul 2008, 10:42:43 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact